SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001297184-23-000074
Filing Date
2023-09-15
Accepted
2023-09-15 16:11:54
Documents
19
Period of Report
2023-09-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amph-20230911x8k.htm   iXBRL 8-K 82488
2 EX-4.1 amph-20230911xex4d1.htm EX-4.1 965187
3 EX-10.1 amph-20230911xex10d1.htm EX-10.1 391961
4 EX-99.1 amph-20230911xex99d1.htm EX-99.1 12169
5 EX-99.2 amph-20230911xex99d2.htm EX-99.2 13919
6 GRAPHIC amph-20230911xex10d1001.jpg GRAPHIC 29673
7 GRAPHIC amph-20230911xex4d1001.jpg GRAPHIC 831
8 GRAPHIC amph-20230911xex4d1002.jpg GRAPHIC 747
  Complete submission text file 0001297184-23-000074.txt   1869709

Data Files

Seq Description Document Type Size
9 EX-101.SCH amph-20230911.xsd EX-101.SCH 3363
10 EX-101.LAB amph-20230911_lab.xml EX-101.LAB 15361
11 EX-101.PRE amph-20230911_pre.xml EX-101.PRE 10385
13 EXTRACTED XBRL INSTANCE DOCUMENT amph-20230911x8k_htm.xml XML 4681
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36509 | Film No.: 231258869
SIC: 2834 Pharmaceutical Preparations